Archives

Excelera Network Welcomes Rush University Medical Center to Optimize and Innovate Specialty Pharmacy Services 204 115 Shields Health Solutions

Excelera Network Welcomes Rush University Medical Center to Optimize and Innovate Specialty Pharmacy Services

MINNEAPOLIS, MN, December 21, 2020 — Rush University Medical Center (RUMC) has partnered with Excelera®, the company behind the Excelera Network, making it the second Excelera Network member in the…

Meet HOSP: The Health System Owned Specialty Pharmacy Alliance 1024 576 Shields Health Solutions

Meet HOSP: The Health System Owned Specialty Pharmacy Alliance

Much like us at Shields Health Solutions, the fully integrated specialty pharmacies market is growing rapidly. It became clear that there needed to be a trade organization committed to advocating…

JAMA Network Open Reports Specialty Pharmacy Partnership Between Shields Health Solutions and UMass Memorial Medical Center Yields Significant Reduction in Total Cost of Care for Patients Filling Prescriptions at Hospital Pharmacy 843 317 Shields Health Solutions

JAMA Network Open Reports Specialty Pharmacy Partnership Between Shields Health Solutions and UMass Memorial Medical Center Yields Significant Reduction in Total Cost of Care for Patients Filling Prescriptions at Hospital Pharmacy
An article published n the Journal of the American Medical Association (JAMA) Network Open, a three-year study (2016-2018) revealed that patients living with chronic illnesses such as cancer, transplants, rheumatoid arthritis, and other diseases were associated with significantly lower total medical expenditure when filling their prescriptions at the hospital’s own specialty pharmacy, rather than using an outside specialty pharmacy.
ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit 204 115 Shields Health Solutions

ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summit
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
COVID — Potential Impact on PBMS and Payers 1024 152 Shields Health Solutions

COVID — Potential Impact on PBMS and Payers

Most Americans seem to be moving on from initial COVID-19 panic, and we are seeing states follow suit by systematically putting plans in place to open back up. This post-pandemic…

How Health System Specialty Pharmacies Will Help Payers Succeed in a Value-Based, Data-Driven Future 204 115 Shields Health Solutions

How Health System Specialty Pharmacies Will Help Payers Succeed in a Value-Based, Data-Driven Future

This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services 204 115 Shields Health Solutions

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services
This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included. • Home infusion is a growing category. • Many health systems find that home infusion aligns with clinical and financial goals. • A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.
Shields Health Solutions Receives Equity Investments From Welsh, Carson, Anderson & Stowe and Walgreen Co. 288 175 Shields Health Solutions

Shields Health Solutions Receives Equity Investments From Welsh, Carson, Anderson & Stowe and Walgreen Co.

STOUGHTON, Mass. & NEW YORK & DEERFIELD, Ill.–(BUSINESS WIRE)–Shields Health Solutions, Welsh, Carson, Anderson & Stowe (“WCAS”) and Walgreen Co. (“Walgreens”) today announced the parties have entered into a definitive…